Ustekinumab 90mg + 130 mg
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| 0752/2022-SML | 11. 05. 2022 | Janssen-Cilag s.r.o. | 35 375 109,44 | 32 159 190,40 | 35 375 109,44 | 32 159 190,40 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| Písemná zpráva Ustekinumab 90+130 signed 24052022.pdf | Písemná zpráva zadavatele | 24. 05. 2022 14:42 | Dokument není zavirovaný |
List of Participants
| Show detail | ||||||
|---|---|---|---|---|---|---|
| Janssen-Cilag s.r.o. | Praha |
Price Actually Paid in Each Year of Performance
| 0752/2022-SML | 2023 | 10 468 893,84 | 9 517 175,52 |
| 0752/2022-SML | 2022 | 7 352 046,42 | 6 683 678,16 |